Genevieve Ameye
Leuven, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Optical Genome Mapping Is a Powerful Diagnostic Tool in Non-Hodgkin Lymphoma.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: July 10, 2025
The Use of Optical Genome Mapping for the Detection of Tyrosine Kinase Gene Fusions in Myeloid/Lymphoid Neoplasms.
Journal: Journal of cellular and molecular medicine
Published: May 05, 2025
The complex karyotype in hematological malignancies: a comprehensive overview by the Francophone Group of Hematological Cytogenetics (GFCH).
Journal: Leukemia
Published: November 24, 2021
Optimizing the diagnostic workflow for acute lymphoblastic leukemia by optical genome mapping.
Journal: American journal of hematology
Published: October 16, 2021
Ultra-low depth sequencing of plasma cell DNA for the detection of copy number aberrations in multiple myeloma.
Journal: Genes, chromosomes & cancer
Published: December 28, 2019
FER and FES tyrosine kinase fusions in follicular T-cell lymphoma.
Journal: Blood
Published: November 21, 2019
Characterization of two new high-grade B-cell lymphoma cell lines with MYC and BCL2 rearrangements that are suitable for in vitro drug sensitivity studies.
Journal: Leukemia & lymphoma
Published: October 03, 2018
Aneurysmal bone cystic lesions: value of genomic studies.
Journal: Acta orthopaedica Belgica
Published: November 29, 2017
Cytogenetics in the management of multiple myeloma: an update by the Groupe francophone de cytogénétique hématologique (GFCH).
Journal: Annales de biologie clinique
Published: October 07, 2016
The peculiar 11q-gain/loss aberration reported in a subset of MYC-negative high-grade B-cell lymphomas can also occur in a MYC-rearranged lymphoma.
Journal: Cancer genetics
Published: December 03, 2015
Last Updated: 09/26/2026